The event, which combines the analysis of trends, scientific innovation, and training through academic content, will be held at the Barcelona international Convention Center in Barcelona, Spain.
Dr Umar Jan, President European Operations, will be presenting on 16 June on the company’s Curcumin C3 Reduct, which is the only EFSA approved pharmacologically active curcumin metabolite. Products featured at the show include Cirpusins, Nigellin, Shagandha, and Starmeric.
Visitors to Sabinsa‘s booth A60 will learn about the significance and attributes on the above products with the company’s Iberian sales associate Ms Aida Arnaiz who will be available to answer questions on actives, the science on ingredients, and product concepts.
“The Sabinsa Iberian staff are looking forward to this show to reconnect in person with customers,” said Dr Jan. “It will also support increasing our footprint in Spain & Portugal.”
